Whether patients with clinical stage I nonseminomatous testicular germ-cell cancer (NSGCT) should be treated with orchiectomy and retroperitoneal lymph node dissection (RPLND) or orchiectomy and surveillance remains
Axel Heidenreich, MD
Advertisement
Articles by Axel Heidenreich, MD
Advertisement
Latest Updated Articles
- Prognostic Factors in Low-Stage Nonseminomatous Testicular Cancer
Published: August 31st 1996 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
This Week in Oncology: FDA Approval Shakeups and Key SITC 2025 Data
2
How Can Chlorotoxin-Directed CAR T-Cell Therapy Impact Glioblastoma Care?
3
What is the Current State of ADC Treatment in EGFR-Amplified Glioblastoma?
4
Identifying Common Toxicities with Targeted Therapies in GI Malignancies
5
